The global Cell Line Development Market was valued at USD 5.46 billion in 2023, projected to reach USD 12.56 billion by 2032 with a CAGR of 9.66%. The U.S. Cell Line Development Market is expected to reach USD 3.52 billion by 2032, growing at a CAGR of 9.68%. Demand for biologics and biosimilars is driving market growth, with advancements in cell line engineering and applications in gene therapy and monoclonal antibody production.

Major players in the Cell Line Development Market include Thermo Fisher Scientific Inc., Sartorius AG, Promega Corporation, Merck KGaA, and more. The market is rapidly growing as biotech companies utilize new gene editing tools to create high-performance cell lines for biologics manufacturing. The U.S. leads the North American market, supported by academic research institutions and biopharmaceutical companies.

In 2023, the Reagents and Media segment dominated the cell line development market, while the Mammalian Cell Line segment accounted for the largest market share. Recombinant Cell Lines were the most dominant type of cell line, with the Bioproduction segment leading in applications. North America held the largest market share in 2023, with Asia Pacific showing the fastest growth rate at 10.40% CAGR.

Recent developments include WuXi Biologics launching a next-generation CHO expression system and MIMETAS unveiling a microvascularized liver model for drug discovery. Exclusive sections of the report cover market adoption rates, R&D investments, biopharmaceutical production trends, environmental metrics analysis, and innovation benchmarks in cell line development. The Cell Line Development Market is expected to reach US$ 12.56 billion by 2032, with a CAGR of 9.66% from 2024 to 2032. Key segments include products & services, source, type of cell line, and application. Regional analysis covers North America, Europe, Asia Pacific, Middle East & Africa, and Latin America.

SNS Insider offers detailed analysis and outlook on the Cell Line Development Market. For more information or customization, contact [email protected]. SNS Insider is a leading global market research and consulting agency, providing clients with up-to-date market data, consumer insights, and opinions to make confident decisions in changing environments.

Read more at GlobeNewswire: Cell Line Development Market to Reach USD 12.56 Billion by